Cassava Sciences Inc. buy Ruckelsbuckel
Start price
01.08.22
/
60%
€16.29
Target price
01.08.23
€64.00
Performance (%)
21.62%
End price
09.08.22
€19.81
Summary
This prediction ended on 09.08.22 with a price of €19.81. The prediction had a final performance of 21.62%. Ruckelsbuckel has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cassava Sciences Inc. | -1.822% | -1.822% | 1.086% |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to Ruckelsbuckel what are the pros and cons of Cassava Sciences Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Rising EBIT margin expected
Fair valuation
High dividend yield expected
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Leading role in innovation
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Top 10 in its market
Small cyclical dependencies
Known brand
Good rating
Standard Investments for future growth
Very good company culture
Some uniques
Very Future proof/growth oriented business model
Cons
Risky balance sheet
high free float
High risks for its business
negative Cash Flow expected